Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells

Dorina Ujvari, Noemi Nagy, Harsha S. Madapura, Tomasz Kallas, Marijke C.L. Kröhnke, Leif Stenke, Eva Klein, D. Salamon

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

B-cell CLL/lymphoma 6 (BCL6) is a transcriptional master regulator that can repress more than 1200 potential target genes. It exerts oncogenic effects through the inhibition of differentiation, DNA damage sensing and apoptosis in several human hematopoietic malignancies, including multiple myeloma (MM). The multifunctional cytokine interferon γ (IFNγ) exerts pro-apoptotic and anti-proliferative effects on MM cells in vitro, at least partially through the inhibition of the effects of interleukin 6 (IL6), one of the most important growth factor of MM and a strong inducer of BCL6 expression. However, IFNγ was also reported to directly upregulate BCL6 in several cell types. These observations prompted us to analyze the effect of IFNγ on BCL6 expression in MM cells. We discovered that among several myeloma growth/survival factors tested (including IL6, oncostatin M, insulin-like growth factor 1, tumor necrosis factor α and IFNα) IFNγ was the strongest inducer of BCL6 mRNA and protein expression in MM cell lines. IFNγ induced upregulation of BCL6 was dependent on the classical STAT1 signaling pathway, and affected both major BCL6 variants. Interestingly, although IFNα induced stronger STAT1 phosphorylation than IFNγ it only slightly upregulated BCL6 in MM lines. We proved that IFNα induced BCL6 upregulation was limited by the concomitant activation of STAT5 signaling. We assume that BCL6 upregulation may represent a potentially pro-tumorigenic effect of IFNγ signaling in MM cells.

Original languageEnglish
Pages (from-to)502-508
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume498
Issue number3
DOIs
Publication statusPublished - Apr 6 2018

Fingerprint

B-Cell Lymphoma
Helper-Inducer T-Lymphocytes
Multiple Myeloma
Interferons
Up-Regulation
Interleukin-6
Intercellular Signaling Peptides and Proteins
Cells
Oncostatin M
Phosphorylation
Somatomedins
Hematologic Neoplasms
DNA Damage
Tumor Necrosis Factor-alpha
Genes
Chemical activation
Apoptosis
Cytokines
Cell Line
Messenger RNA

Keywords

  • BCL6
  • IFNγ
  • Multiple myeloma
  • STAT1
  • STAT5

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells. / Ujvari, Dorina; Nagy, Noemi; Madapura, Harsha S.; Kallas, Tomasz; Kröhnke, Marijke C.L.; Stenke, Leif; Klein, Eva; Salamon, D.

In: Biochemical and Biophysical Research Communications, Vol. 498, No. 3, 06.04.2018, p. 502-508.

Research output: Contribution to journalArticle

Ujvari, Dorina ; Nagy, Noemi ; Madapura, Harsha S. ; Kallas, Tomasz ; Kröhnke, Marijke C.L. ; Stenke, Leif ; Klein, Eva ; Salamon, D. / Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells. In: Biochemical and Biophysical Research Communications. 2018 ; Vol. 498, No. 3. pp. 502-508.
@article{1d32a9b0ee134a75853501665d5b2848,
title = "Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells",
abstract = "B-cell CLL/lymphoma 6 (BCL6) is a transcriptional master regulator that can repress more than 1200 potential target genes. It exerts oncogenic effects through the inhibition of differentiation, DNA damage sensing and apoptosis in several human hematopoietic malignancies, including multiple myeloma (MM). The multifunctional cytokine interferon γ (IFNγ) exerts pro-apoptotic and anti-proliferative effects on MM cells in vitro, at least partially through the inhibition of the effects of interleukin 6 (IL6), one of the most important growth factor of MM and a strong inducer of BCL6 expression. However, IFNγ was also reported to directly upregulate BCL6 in several cell types. These observations prompted us to analyze the effect of IFNγ on BCL6 expression in MM cells. We discovered that among several myeloma growth/survival factors tested (including IL6, oncostatin M, insulin-like growth factor 1, tumor necrosis factor α and IFNα) IFNγ was the strongest inducer of BCL6 mRNA and protein expression in MM cell lines. IFNγ induced upregulation of BCL6 was dependent on the classical STAT1 signaling pathway, and affected both major BCL6 variants. Interestingly, although IFNα induced stronger STAT1 phosphorylation than IFNγ it only slightly upregulated BCL6 in MM lines. We proved that IFNα induced BCL6 upregulation was limited by the concomitant activation of STAT5 signaling. We assume that BCL6 upregulation may represent a potentially pro-tumorigenic effect of IFNγ signaling in MM cells.",
keywords = "BCL6, IFNγ, Multiple myeloma, STAT1, STAT5",
author = "Dorina Ujvari and Noemi Nagy and Madapura, {Harsha S.} and Tomasz Kallas and Kr{\"o}hnke, {Marijke C.L.} and Leif Stenke and Eva Klein and D. Salamon",
year = "2018",
month = "4",
day = "6",
doi = "10.1016/j.bbrc.2018.03.010",
language = "English",
volume = "498",
pages = "502--508",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells

AU - Ujvari, Dorina

AU - Nagy, Noemi

AU - Madapura, Harsha S.

AU - Kallas, Tomasz

AU - Kröhnke, Marijke C.L.

AU - Stenke, Leif

AU - Klein, Eva

AU - Salamon, D.

PY - 2018/4/6

Y1 - 2018/4/6

N2 - B-cell CLL/lymphoma 6 (BCL6) is a transcriptional master regulator that can repress more than 1200 potential target genes. It exerts oncogenic effects through the inhibition of differentiation, DNA damage sensing and apoptosis in several human hematopoietic malignancies, including multiple myeloma (MM). The multifunctional cytokine interferon γ (IFNγ) exerts pro-apoptotic and anti-proliferative effects on MM cells in vitro, at least partially through the inhibition of the effects of interleukin 6 (IL6), one of the most important growth factor of MM and a strong inducer of BCL6 expression. However, IFNγ was also reported to directly upregulate BCL6 in several cell types. These observations prompted us to analyze the effect of IFNγ on BCL6 expression in MM cells. We discovered that among several myeloma growth/survival factors tested (including IL6, oncostatin M, insulin-like growth factor 1, tumor necrosis factor α and IFNα) IFNγ was the strongest inducer of BCL6 mRNA and protein expression in MM cell lines. IFNγ induced upregulation of BCL6 was dependent on the classical STAT1 signaling pathway, and affected both major BCL6 variants. Interestingly, although IFNα induced stronger STAT1 phosphorylation than IFNγ it only slightly upregulated BCL6 in MM lines. We proved that IFNα induced BCL6 upregulation was limited by the concomitant activation of STAT5 signaling. We assume that BCL6 upregulation may represent a potentially pro-tumorigenic effect of IFNγ signaling in MM cells.

AB - B-cell CLL/lymphoma 6 (BCL6) is a transcriptional master regulator that can repress more than 1200 potential target genes. It exerts oncogenic effects through the inhibition of differentiation, DNA damage sensing and apoptosis in several human hematopoietic malignancies, including multiple myeloma (MM). The multifunctional cytokine interferon γ (IFNγ) exerts pro-apoptotic and anti-proliferative effects on MM cells in vitro, at least partially through the inhibition of the effects of interleukin 6 (IL6), one of the most important growth factor of MM and a strong inducer of BCL6 expression. However, IFNγ was also reported to directly upregulate BCL6 in several cell types. These observations prompted us to analyze the effect of IFNγ on BCL6 expression in MM cells. We discovered that among several myeloma growth/survival factors tested (including IL6, oncostatin M, insulin-like growth factor 1, tumor necrosis factor α and IFNα) IFNγ was the strongest inducer of BCL6 mRNA and protein expression in MM cell lines. IFNγ induced upregulation of BCL6 was dependent on the classical STAT1 signaling pathway, and affected both major BCL6 variants. Interestingly, although IFNα induced stronger STAT1 phosphorylation than IFNγ it only slightly upregulated BCL6 in MM lines. We proved that IFNα induced BCL6 upregulation was limited by the concomitant activation of STAT5 signaling. We assume that BCL6 upregulation may represent a potentially pro-tumorigenic effect of IFNγ signaling in MM cells.

KW - BCL6

KW - IFNγ

KW - Multiple myeloma

KW - STAT1

KW - STAT5

UR - http://www.scopus.com/inward/record.url?scp=85042927521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042927521&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2018.03.010

DO - 10.1016/j.bbrc.2018.03.010

M3 - Article

C2 - 29510136

AN - SCOPUS:85042927521

VL - 498

SP - 502

EP - 508

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -